Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

B. Dawson-Hughes, A. N A Tosteson, L. J. Melton, S. Baim, M. J. Favus, S. Khosla, R. L. Lindsay

Research output: Contribution to journalArticle

299 Citations (Scopus)

Abstract

Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations. Introduction: The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment. Methods: The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability (%) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3%. Results: It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and nonwhite women compared to postmenopausal white women. Conclusions: This analysis generally endorsed existing clinical practice recommendations, but specific treatment decisions must be individualized. An estimate of the patient's 10-year fracture risk should facilitate shared decision-making.

Original languageEnglish
Pages (from-to)449-458
Number of pages10
JournalOsteoporosis International
Volume19
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Practice Guidelines
Osteoporosis
Hip Fractures
Health Care Costs
Economics
Economic Models
Osteoporotic Fractures
Incidence
Population
Decision Making
Costs and Cost Analysis
Mortality
Therapeutics

Keywords

  • Fracture prediction
  • National Osteoporosis Foundation
  • Osteoporosis
  • Practice guidelines
  • World Health Organization

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Dawson-Hughes, B., Tosteson, A. N. A., Melton, L. J., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008). Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporosis International, 19(4), 449-458. https://doi.org/10.1007/s00198-008-0559-5

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. / Dawson-Hughes, B.; Tosteson, A. N A; Melton, L. J.; Baim, S.; Favus, M. J.; Khosla, S.; Lindsay, R. L.

In: Osteoporosis International, Vol. 19, No. 4, 01.04.2008, p. 449-458.

Research output: Contribution to journalArticle

Dawson-Hughes, B, Tosteson, ANA, Melton, LJ, Baim, S, Favus, MJ, Khosla, S & Lindsay, RL 2008, 'Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA', Osteoporosis International, vol. 19, no. 4, pp. 449-458. https://doi.org/10.1007/s00198-008-0559-5
Dawson-Hughes, B. ; Tosteson, A. N A ; Melton, L. J. ; Baim, S. ; Favus, M. J. ; Khosla, S. ; Lindsay, R. L. / Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. In: Osteoporosis International. 2008 ; Vol. 19, No. 4. pp. 449-458.
@article{772b492b88b8469091caf6a6f410fc57,
title = "Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA",
abstract = "Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations. Introduction: The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment. Methods: The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability ({\%}) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3{\%}. Results: It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and nonwhite women compared to postmenopausal white women. Conclusions: This analysis generally endorsed existing clinical practice recommendations, but specific treatment decisions must be individualized. An estimate of the patient's 10-year fracture risk should facilitate shared decision-making.",
keywords = "Fracture prediction, National Osteoporosis Foundation, Osteoporosis, Practice guidelines, World Health Organization",
author = "B. Dawson-Hughes and Tosteson, {A. N A} and Melton, {L. J.} and S. Baim and Favus, {M. J.} and S. Khosla and Lindsay, {R. L.}",
year = "2008",
month = "4",
day = "1",
doi = "10.1007/s00198-008-0559-5",
language = "English",
volume = "19",
pages = "449--458",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "4",

}

TY - JOUR

T1 - Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

AU - Dawson-Hughes, B.

AU - Tosteson, A. N A

AU - Melton, L. J.

AU - Baim, S.

AU - Favus, M. J.

AU - Khosla, S.

AU - Lindsay, R. L.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations. Introduction: The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment. Methods: The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability (%) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3%. Results: It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and nonwhite women compared to postmenopausal white women. Conclusions: This analysis generally endorsed existing clinical practice recommendations, but specific treatment decisions must be individualized. An estimate of the patient's 10-year fracture risk should facilitate shared decision-making.

AB - Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations. Introduction: The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment. Methods: The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability (%) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3%. Results: It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and nonwhite women compared to postmenopausal white women. Conclusions: This analysis generally endorsed existing clinical practice recommendations, but specific treatment decisions must be individualized. An estimate of the patient's 10-year fracture risk should facilitate shared decision-making.

KW - Fracture prediction

KW - National Osteoporosis Foundation

KW - Osteoporosis

KW - Practice guidelines

KW - World Health Organization

UR - http://www.scopus.com/inward/record.url?scp=44649157879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649157879&partnerID=8YFLogxK

U2 - 10.1007/s00198-008-0559-5

DO - 10.1007/s00198-008-0559-5

M3 - Article

VL - 19

SP - 449

EP - 458

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 4

ER -